FABP5P3: A Fatty Acid Binding Protein 5 Pseudogene 3 as a Drug Target and Biomarker

Target Name: FABP5P3

NCBI ID: G220832

FABP5P3

Other Name(s): Fatty acid binding protein 5 pseudogene 3 | FABP5L3 | fatty acid binding protein 5 pseudogene 3

FABP5P3: A Fatty Acid Binding Protein 5 Pseudogene 3 as a Drug Target and Biomarker

Abstract:

Fatty acid binding protein 5 (FABP5) is a protein that has been identified as a potential drug target and biomarker. FABP5 has been shown to play a crucial role in various cellular processes, including cell signaling, DNA replication, and metabolism. In this article, we will discuss the FABP5 protein, its functions, and its potential as a drug target and biomarker.

Introduction:

Fatty acid binding protein 5 (FABP5) is a gene that encodes a protein that is expressed in various tissues and cells of the human body. FABP5 has been shown to play a crucial role in various cellular processes, including cell signaling, DNA replication, and metabolism.

FABP5 is a protein that is characterized by its ability to bind fatty acids, which is essential for various cellular processes. FABP5 has been shown to interact with various cellular signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway.

Drug Targeting:

FABP5 has been identified as a potential drug target due to its involvement in various cellular processes that are associated with various diseases, including cancer, cardiovascular disease, and neurodegenerative diseases.

One of the potential drug targets for FABP5 is the inhibition of FABP5-mediated signaling pathways. Various studies have shown that the inhibition of FABP5 can lead to the inhibition of various cellular signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway.

FABP5 has also been shown to be involved in the regulation of cellular apoptosis, which is a critical process that helps eliminate damaged or dysfunctional cells. The inhibition of FABP5 has been shown to lead to the inhibition of cellular apoptosis, which can lead to the development of cancer.

Biomarker:

FABP5 has also been identified as a potential biomarker for various diseases, including cancer, cardiovascular disease, and neurodegenerative diseases.

Studies have shown that the expression of FABP5 is significantly increased in various tissues and cells of cancer patients, and that the inhibition of FABP5 has been shown to lead to the inhibition of the growth and survival of cancer cells.

FABP5 has also been shown to be involved in the regulation of cellular signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway. The inhibition of FABP5 has been shown to lead to the inhibition of these pathways, which can lead to the development of cardiovascular disease and neurodegenerative diseases.

Conclusion:

FABP5 is a protein that has been identified as a potential drug target and biomarker. FABP5 has been shown to play a crucial role in various cellular processes, including cell signaling, DNA replication, and metabolism. The inhibition of FABP5 has been shown to lead to the inhibition of various cellular signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway. FABP5 has also been shown to be involved in the regulation of cellular apoptosis and has been identified as a potential biomarker for various diseases, including cancer, cardiovascular disease, and neurodegenerative diseases. Further research is needed to fully understand the role of FABP5 in various cellular processes and its potential as a drug target and biomarker.

Protein Name: Fatty Acid Binding Protein 5 Pseudogene 3

Functions: High specificity for fatty acids

The "FABP5P3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FABP5P3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets